Skip to main content

Table 1 Baseline data for the survival and death groups of cancer patients with sepsis

From: Brain natriuretic peptide and cardiac troponin I for prediction of the prognosis in cancer patients with sepsis

 

Total (n = 233)

Survival (n = 190)

death (n = 43)

P

Sex, male

169(72.5 %)

139(73.2 %)

30(69.8 %)

0.65

Age(year)

63.7 ± 9.9

63.5 ± 9.9

64.9 ± 10.1

0.4

Infection category

  Respiratory

79(33.9 %)

66(34.7 %)

13(30.2 %)

0.21

Gastrointestinal

17(7.3 %)

11(7.9 %)

4(9.3 %)

0.32

Abdominal cavity

99(42.3 %)

80(42.1 %)

18(41.9 %)

0.54

Thoracic cavity

27(11.6 %)

23(12.1 %)

7(16.2 %)

0.14

Catheter related blood stream infection

3(1.3 %)

3(1.6 %)

0

0.13

Genitourinary

5(2.1 %)

5(2.1 %)

0

0.21

Others

3(1.3 %)

2(1.1 %)

1(2.3 %)

0.16

Septic shock

94(40.3 %)

60(31.6 %)

34(79.1 %)

0.001

AKI

40(17.2 %)

14(7.4 %)

26(60.5 %)

0.001

ARF

123(52.3 %)

88(46.3 %)

35(81.4 %)

0.001

SIMD a

42/126 (33.3 %)

30/98(30.6 %)

12/28(42.9)

0.26

Total MV time(day)

3.6 ± 5.9

2.7 ± 4.7

7.5 ± 8.7

0.001

ICU stay time(day)

7.8 ± 5.9

7.7 ± 5.3

8.6 ± 7.7

0.46

Fluid-balance(ml/kg)

24 hr

49.4 ± 35.8

46.1 ± 33.1

53.9 ± 43.3

0.083

72 hr

63.1 ± 54.9

50.5 ± 45.8

118.5 ± 58.2

0.002

Emergency surgery

62(26.7 %)

51(26.8 %)

11(25.6 %)

0.26

Lactate(mmol/l)

2.9 ± 2.2

2.6 ± 1.6

4.6 ± 3.5

0.001

Leucocyte (10^9/l)

13.3 ± 8.3

13.2 ± 8.4

13.7 ± 8.3

0.73

PCT (ng/ml)

17.6 ± 45.2

15.7 ± 43.6

25.4 ± 51.5

0.21

Cardiac biomarkers

BNP (pg/ml)

d1

673.6 ± 786.6

618.1 ± 724.7

919.0 ± 989.6

0.01

d3

656.6 ± 912.4

370.2 ± 456.9

1922.1 ± 1284.1

0.000

cTnI(ng/ml)

d1

0.04(0.02/0.17)

0.03(0.01/0.16)

0.08(0.03/0.23)

0.04

d3

0.03(0.01/0.12)

0.02(0.01/0.05)

0.21(0.11/1.11)

0.02

SOFA Score

5(4/10)

4(3/7)

9(4/12)

0.000

  1. Data were expressed as mean ± standard deviation, number (percentage), or median (25th/75th percentile). AKI acute kidney injury; ARF acute respiratory failure; SIMD sepsis-induced myocardial dysfunction; CRRT continuous renal replacement therapy; MV mechanical ventilation; ICU intensive care unit; PCT Procalcitonin; BNP brain natriuretic peptide; cTnI cardiac troponin I; 24hr In 24hr after entering ICU; 72 hr In 72 h after entering ICU; d1 the first day in ICU; d3 the third day in ICU; SOFA Sequential Organ failure assessment. a126 out of 233 patients underwent bedside echocardiogram